Cart
Free US shipping over $10
Proud to be B-Corp

Dose Optimization in Drug Development Markus Muller (Univ.-Klinik fur Klinische Pharmacologie, Vienna, Austria)

Dose Optimization in Drug Development By Markus Muller (Univ.-Klinik fur Klinische Pharmacologie, Vienna, Austria)

Dose Optimization in Drug Development by Markus Muller (Univ.-Klinik fur Klinische Pharmacologie, Vienna, Austria)


$315.19
Condition - New
Only 2 left

Summary

Dose Optimization in Drug Development

Dose Optimization in Drug Development Summary

Dose Optimization in Drug Development by Markus Muller (Univ.-Klinik fur Klinische Pharmacologie, Vienna, Austria)

This reference provides a concise overview of the key principles in dose selection and optimization and demonstrates applicability to recent successful new drug applications. Compiling key issues and current research on safety, efficacy, and clinical pharmacology, and PK-PD, this volume critically highlights the multidisciplinary nature of drug development and spans the fields of pharmacokinetics, clinical pharmacology, biostatistics, and experimental medicine.

About Markus Muller (Univ.-Klinik fur Klinische Pharmacologie, Vienna, Austria)

Rajesh Krishna

Table of Contents

Introduction to Dose Optimization in Drug Development. Bridging Preclinical and Clinical Development: Disease Progression Modeling in Translational Research. Bridging Preclinical and Clinical Development: Biomarker Validation and Qualification. Dose Selection for First-In-Human Study: A Regulatory Perspective. Novel Clinical Trial Designs in Clinical Pharmacology and Experimental Medicine. Biomarkers, Surrogate Endpoints, and Clinical Endpoints in the Development of Cardiovascular Drugs: A Regulatory Perspective. Pharmacokinetic and Pharmacodynamic Variability. Pharmacogenetics and Dose Response: Dose Individualization. Optimal Dose Finding in Drug Development: Approaches and Regulatory Perspectives. Optimal Dose Selection in Drug Development: Role of Population Pharmacokinetics in Phase 3. Dose Optimization Strategy for Strattera, A CYP2D6 Substrate. Pediatric Dose Optimization Using Pharmacokinetics/Pharmacodynamics

Additional information

NPB9781574448085
9781574448085
1574448080
Dose Optimization in Drug Development by Markus Muller (Univ.-Klinik fur Klinische Pharmacologie, Vienna, Austria)
New
Hardback
Taylor & Francis Inc
2006-05-01
320
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Dose Optimization in Drug Development